Epocrates Inc., a San Mateo, Calif.-based provider of clinical information and support tools to healthcare professionals, has filed for a $75 million IPO. It originally filed for a $75 million IPO in April 2008, but withdrew later that year, telling the SEC that its offering would have been “discretionary financing.”
The company plans to trade on the Nasdaq under ticker symbol EPOC, with J.P. Morgan and Piper Jaffray serving as co-lead underwriters. Citi had been listed as sole underwriter on the previous S-1, but is not mentioned in the latest filing.
The company has raised over $86 million in VC funding, from firms like The Sprout Group (17.2% stake), Goldman Sachs (16.2%), InterWest Partners (12.8%), Draper Fisher Jurvetson (10.5%), Three Arch Partners (10.4%) and Bay City Capital (7.4%). www.epocrates.com
Take your pick!
- Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
- VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.